Objective: There are no current effective abdominal aortic aneurysm (AAA) drug therapies.
An important limitation of most preclinical studies is that they test the effect of drugs on AAA …

Background Rupture of abdominal aortic aneurysm (AAA) is one of the leading causes of
sudden death among the elderly. Most incidental AAAs are below the threshold for …

Adaptive immunity and innate immunity have been implicated in the pathogenesis of
abdominal aortic aneurysm (AAA), and damage and remodelling in the tunica media are a …

Rupture of Abdominal aortic aneurysm (AAA) is among the 15 leading causes of death after
age 65. Using high frequency ultrasound, we showed that photobiomodulation (PBM) …

Chronically sustained systemic hypertension in dogs can damage the kidneys, eye, brain,
heart, and vessels. In human medicine, systemic hypertension has been implicated as the …

Various research studies have been conducted in deducing the role of microRNAs
(miRNAs) in the pathogenesis and physiological processes of various systematic diseases …

Objective/background Elevated arterial stiffness is a characteristic of abdominal aortic
aneurysm (AAA), and is associated with AAA growth and cardiovascular mortality. A bout of …

Aortic pathologies such as aneurysm, dissection and trauma are relatively common and
potentially fatal diseases. Over the past two decades, we have experienced unprecedented …

Abstract Objectives Glucagon-like peptide-1 (GLP-1) has a cardiovascular protective effect
by preventing abdominal aortic aneurysm (AAA) formation. However, it is unclear at what …

An abdominal aortic aneurysm (AAA) is a degenerative pathology that affects the infrarenal
segment of the aorta, leading to its progressive dilatation and eventually rupture. The …